Loading...
B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients
BackgroundVaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral and cellular responses upon vaccination. The ability to pre...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.822885/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|